skip to content

Department of Chemical Engineering and Biotechnology


Heikki and Dan

During 2003, Heikki Lanckriet (on the left in the photograph) and Daniel Jones (on the right) of the Department of Chemical Engineering formed Novexin and won £10,000 in the Cambridge University Entrepreneurs Business Plan Competition.

Novexin is a biotechnology company seeking to further develop and commercialise its proprietary protein processing technology. The company is addressing the need for protein purification and refolding techniques that are robust, high-yielding and easy to scale-up for industrial production.

In February 2004, they announced that Novexin has acquired technology, originating from Cambridge University, to produce proteins from DNA through a novel protein refolding process and that they have raised £400,000 in seed investment from investors including Cambridge Capital Group and business angels to further develop the process.

Latest news

From PhD student to CEO

15 August 2019

Alumnus founds microcapsule start-up for the product industry

July paper of the month: Christie lab discovers two new enzymes responsible for spore germination

9 August 2019

Researchers from our Molecular Microbiology group have identified two new enzymes responsible for breaking open bacterial spores when they germinate.

Dr Marta Serrani through to semi-finals of the Postdoc Business Plan Competition

8 August 2019

Dr Serrani’s start-up, Polivalve, will look to bring the prosthetic heart valves developed by our structured materials research group to the market.